Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
EBioMedicine (2022) Vol. 87, pp. 104402-104402
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 47
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Felicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 607-621
Open Access | Times Cited: 33
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
Helen R. Wagstaffe, Ryan S. Thwaites, Arnold Reynaldi, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 25
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
Béré Diallo, Caitlín Ní Chasaide, Ting Y. Wong, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
Shaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Hailey Hornsby, Alexander R. Nicols, Stéphanie Longet, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine
Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Victor Augusti Negri, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Oscar Bladh, Katherina Aguilera, Ulrika Marking, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy Russell, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0294897-e0294897
Open Access | Times Cited: 7
A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
Hongwei Shen, Dingqiang Chen, Chenglin Li, et al.
Health Science Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 7
Primary nasal influenza infection rewires tissue-scale memory response dynamics
Samuel W. Kazer, Colette Matysiak Match, Erica M. Langan, et al.
Immunity (2024) Vol. 57, Iss. 8, pp. 1955-1974.e8
Closed Access | Times Cited: 7
Promises and challenges of mucosal COVID-19 vaccines
Abhay P. S. Rathore, Ashley L. St. John
Vaccine (2023) Vol. 41, Iss. 27, pp. 4042-4049
Open Access | Times Cited: 18
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses
Divya Sinha, Melyssa Yaugel-Novoa, Louis Waeckel, et al.
Antiviral Research (2024) Vol. 223, pp. 105823-105823
Closed Access | Times Cited: 5
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
Chaochao Qiu, Xiao-Qing Lin, Qiang Zhang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan
Guoxi Cai, Shiwen Liu, Yixiao Lu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia
Sheikh Jarju, Rhys Wenlock, Madikoi Danso, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Durability of immune responses to SARS-CoV-2 infection and vaccination
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses
Olha Puhach, Mathilde Bellon, Kenneth Adea, et al.
EBioMedicine (2023) Vol. 98, pp. 104893-104893
Open Access | Times Cited: 10
Update on Omicron variant and its threat to vulnerable populations
Bowen Dai, Wangquan Ji, Peiyu Zhu, et al.
Public Health in Practice (2024) Vol. 7, pp. 100494-100494
Open Access | Times Cited: 3
Plasmonic Nanograin Metasurface with Disorder‐Enhanced Biosensing for SARS‐CoV‐2 Variant and Antibodies
Fajun Li, Chaoheng Guan, Kaiyun Chen, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 36
Closed Access | Times Cited: 3
Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies
Si Chen, Zhengyuan Zhang, Qian Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top